PubMed COVID-19 Clinical Care
19471 - 19480 of 44979 results found
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
Description
CONCLUSION: The rate of adverse reactions after established vaccinations was roughly comparable to previous studies. Two weeks after vaccination, participants in the SARS-CoV-2 vaccination group reported more local and systemic local reactions than
Curbing the COVID-19 digital infodemic: strategies and tools
Description
A problematic manifestation of the COVID-19 pandemic is a related digital 'infodemic' with widespread dissemination of rumors, conspiracy theories, and other misinformation about the impact of the crisis on aspects of political and socio-economic
A large survey on COVID-19 vaccination in patients with Parkinson's disease and healthy population
Description
CONCLUSIONS: The COVID-19 vaccination rate was remarkably lower in PD patients than healthy individuals in China. The approved vaccines have shown an acceptable safety profile. Our findings would offer a reference to guide future clinical decision
Optimism bias regarding COVID-19: a cross-sectional study of lower-income older adults in Thailand
Description
Objective: Understanding the discernment of individuals about their health is crucial during public health situations such as the COVID-19 pandemic. Within this theme of study is how older adults perceive their vulnerabilities because it can relate
Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States
Description
CONCLUSIONS: A decrease in the incidence of Kawasaki disease during the COVID-19 pandemic was observed nationwide in the United States. Contrary to a report from Japan, we did not observe a relationship between population density and a decrease in
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19
Description
Indigenous peoples globally are at increased risk of COVID-19-associated morbidity and mortality. However, data that describe immune responses to SARS-CoV-2 infection in Indigenous populations are lacking. We evaluated immune responses in Australian
Clinical characteristics, outcomes and risk factors for mortality in hospitalized diabetes and chronic kidney disease patients after COVID-19 infection following widespread vaccination
Description
CONCLUSIONS: These findings highlight the critical importance of identifying and managing comorbid risk factors for COVID-19, especially among the elderly, in order to optimize clinical outcomes, even after COVID-19 vaccination.
The Interferon-Lambda Family Celebrates 20 Years of Scientific Discovery
Description
It has now been 20 years since the original discovery of the interferon λ (IFN-λ) family (Kotenko et al., 2003; Sheppard et al., 2003) and 10 years since the subsequent discovery of IFN-λ4 (Prokunina-Olsson et al., 2013). The IFN-λ family (type III
